4D Molecular Therapeutics, Inc. (FDMT) Deep Dive Video

Name: 4D Molecular Therapeutics, Inc. (FDMT) Deep Dive Video | Flash
Uploaded: 2025-12-20T16:11:14.715
Description: FDMT is priced like liquidation value, but successful Phase 3 proof of safe, durable intravitreal gene therapy could re-rate it into a multi-billion-dollar retinal franchise.

Summary

FDMT is priced like liquidation value, but successful Phase 3 proof of safe, durable intravitreal gene therapy could re-rate it into a multi-billion-dollar retinal franchise.

View FDMT stock page · Read the FDMT research report

Loading the video player…